Profil
Anne Leselbaum worked as Director-Clinical Development at TiGenix NV from 2014 to 2016.
She also worked as Chief Medical Officer at Bone Therapeutics SA and BioSenic SA, and as Vice President-Clinical Development at Aelix Therapeutics SL.
Dr. Leselbaum holds a doctorate degree from Universite Paris Cite.
Anciens postes connus de Anne Leselbaum
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSENIC SA | Directeur Technique/Scientifique/R&D | 02/12/2022 |
| TIGENIX NV | Corporate Officer/Principal | 01/01/2016 |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Corporate Officer/Principal | - |
| BIOSENIC SA | Directeur Technique/Scientifique/R&D | - |
Formation de Anne Leselbaum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Bone Therapeutics SA
Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics | Health Technology |
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Develops novel vaccines to cure HIV infection | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioSenic SA
BioSenic SA BiotechnologyHealth Technology Engages in medical research and develops drugs | Health Technology |
















